# Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects

> **NCT02281370** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 39 (actual)

## Conditions studied

- Purpura, Thrombocytopenic, Idiopathic

## Interventions

- **DRUG:** Eltrombopag
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT02281370
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-05
- **Primary completion:** 2014-12-24
- **Final completion:** 2014-12-24
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02281370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02281370, "Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02281370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*